BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32483379)

  • 21. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
    Zhao H; Cui G; Jin J; Chen X; Xu B
    Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1.
    Innes BT; Sowole MA; Gyenis L; Dubinsky M; Konermann L; Litchfield DW; Brandl CJ; Shilton BH
    Biochim Biophys Acta; 2015 May; 1852(5):905-12. PubMed ID: 25595659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.
    Lian X; Lin YM; Kozono S; Herbert MK; Li X; Yuan X; Guo J; Guo Y; Tang M; Lin J; Huang Y; Wang B; Qiu C; Tsai CY; Xie J; Gao ZJ; Wu Y; Liu H; Zhou XZ; Lu KP; Chen Y
    J Hematol Oncol; 2018 May; 11(1):73. PubMed ID: 29848341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways.
    Liao XH; Zhang AL; Zheng M; Li MQ; Chen CP; Xu H; Chu QS; Yang D; Lu W; Tsai TF; Liu H; Zhou XZ; Lu KP
    Sci Rep; 2017 Mar; 7():43639. PubMed ID: 28262728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a Prenylated Flavonol Derivative as a Pin1 Inhibitor to Suppress Hepatocellular Carcinoma by Modulating MicroRNA Biogenesis.
    Zheng Y; Pu W; Li J; Shen X; Zhou Q; Fan X; Yang SY; Yu Y; Chen Q; Wang C; Wu X; Peng Y
    Chem Asian J; 2019 Jan; 14(1):130-134. PubMed ID: 30474357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysteine-113 covalency inspires the development of Pin1 inhibitor.
    Pu W; Li J; Peng Y
    Signal Transduct Target Ther; 2020 Oct; 5(1):225. PubMed ID: 33024085
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors.
    da Costa KS; Galúcio JM; de Jesus DA; Gomes GC; Lima E Lima AH; Taube PS; Dos Santos AM; Lameira J
    Curr Comput Aided Drug Des; 2020; 16(5):605-617. PubMed ID: 31654518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.
    Ma T; Huang M; Li A; Zhao F; Li D; Liu D; Zhao L
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1859-1863. PubMed ID: 31103446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prolyl isomerase Pin1 increases β-cell proliferation and enhances insulin secretion.
    Nakatsu Y; Mori K; Matsunaga Y; Yamamotoya T; Ueda K; Inoue Y; Mitsuzaki-Miyoshi K; Sakoda H; Fujishiro M; Yamaguchi S; Kushiyama A; Ono H; Ishihara H; Asano T
    J Biol Chem; 2017 Jul; 292(28):11886-11895. PubMed ID: 28566287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Roles of Pin1 in Cancer Development and Progression.
    Han HJ; Choi BY; Surh YJ
    Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
    Cho JH; Chae JI; Shim JH
    Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth.
    Lepore A; Choy PM; Lee NCW; Carella MA; Favicchio R; Briones-Orta MA; Glaser SS; Alpini G; D'Santos C; Tooze RM; Lorger M; Syn WK; Papakyriakou A; Giamas G; Bubici C; Papa S
    Hepatology; 2021 Nov; 74(5):2561-2579. PubMed ID: 34048060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
    Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
    Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer.
    Liang C; Rong Z; Tuerhong A; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Shi S; Xu J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA Biogenesis is Enhanced by Liposome-Encapsulated Pin1 Inhibitor in Hepatocellular Carcinoma.
    Sun D; Tan S; Xiong Y; Pu W; Li J; Wei W; Huang C; Wei YQ; Peng Y
    Theranostics; 2019; 9(16):4704-4716. PubMed ID: 31367251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells.
    Nakatsu Y; Yamamotoya T; Ueda K; Ono H; Inoue MK; Matsunaga Y; Kushiyama A; Sakoda H; Fujishiro M; Matsubara A; Asano T
    Cancer Lett; 2020 Feb; 470():106-114. PubMed ID: 31678165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical role of oncogenic KRAS in pancreatic cancer (Review).
    Liu J; Ji S; Liang C; Qin Y; Jin K; Liang D; Xu W; Shi S; Zhang B; Liu L; Liu C; Xu J; Ni Q; Yu X
    Mol Med Rep; 2016 Jun; 13(6):4943-9. PubMed ID: 27121414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer.
    Kim G; Bhattarai PY; Choi HS
    Arch Pharm Res; 2019 Feb; 42(2):128-139. PubMed ID: 30684192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based design of novel human Pin1 inhibitors (I).
    Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.